Ramírez Fernández María del Mar, Van Durme Filip, Wille Sarah M R, di Fazio Vincent, Kummer Natalie, Samyn Nele
Federal Public Service Justice, National Institute of Criminalistics and Criminology, Chaussée de Vilvorde 100, 1120 Brussels, Belgium.
J Anal Toxicol. 2014 Jun;38(5):280-8. doi: 10.1093/jat/bku024. Epub 2014 Apr 30.
The aim of this work was to automate a sample preparation procedure extracting morphine, hydromorphone, oxymorphone, norcodeine, codeine, dihydrocodeine, oxycodone, 6-monoacetyl-morphine, hydrocodone, ethylmorphine, benzoylecgonine, cocaine, cocaethylene, tramadol, meperidine, pentazocine, fentanyl, norfentanyl, buprenorphine, norbuprenorphine, propoxyphene, methadone and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine from urine samples. Samples were extracted by solid-phase extraction (SPE) with cation exchange cartridges using a TECAN Freedom Evo 100 base robotic system, including a hydrolysis step previous extraction when required. Block modules were carefully selected in order to use the same consumable material as in manual procedures to reduce cost and/or manual sample transfers. Moreover, the present configuration included pressure monitoring pipetting increasing pipetting accuracy and detecting sampling errors. The compounds were then separated in a chromatographic run of 9 min using a BEH Phenyl analytical column on a ultra-performance liquid chromatography-tandem mass spectrometry system. Optimization of the SPE was performed with different wash conditions and elution solvents. Intra- and inter-day relative standard deviations (RSDs) were within ±15% and bias was within ±15% for most of the compounds. Recovery was >69% (RSD < 11%) and matrix effects ranged from 1 to 26% when compensated with the internal standard. The limits of quantification ranged from 3 to 25 ng/mL depending on the compound. No cross-contamination in the automated SPE system was observed. The extracted samples were stable for 72 h in the autosampler (4°C). This method was applied to authentic samples (from forensic and toxicology cases) and to proficiency testing schemes containing cocaine, heroin, buprenorphine and methadone, offering fast and reliable results. Automation resulted in improved precision and accuracy, and a minimum operator intervention, leading to safer sample handling and less time-consuming procedures.
这项工作的目的是实现尿液样本中吗啡、氢吗啡酮、羟吗啡酮、去甲可待因、可待因、二氢可待因、羟考酮、6-单乙酰吗啡、氢可酮、乙基吗啡、苯甲酰爱康宁、可卡因、可口乙酮、曲马多、哌替啶、喷他佐辛、芬太尼、去甲芬太尼、丁丙诺啡、去甲丁丙诺啡、丙氧芬、美沙酮和2-亚乙基-1,5-二甲基-3,3-二苯基吡咯烷提取的样本制备程序自动化。使用TECAN Freedom Evo 100基础机器人系统,通过阳离子交换柱进行固相萃取(SPE)来提取样本,必要时在提取前包括水解步骤。仔细选择模块以使用与手动程序相同的消耗材料,从而降低成本和/或减少手动样本转移。此外,当前配置包括压力监测移液,提高了移液准确性并能检测采样误差。然后,使用超高效液相色谱 - 串联质谱系统上的BEH苯基分析柱,在9分钟的色谱运行中分离这些化合物。通过不同的洗涤条件和洗脱溶剂对SPE进行了优化。大多数化合物的日内和日间相对标准偏差(RSD)在±15%以内,偏差在±15%以内。用内标补偿时回收率>69%(RSD<11%),基质效应范围为1%至26%。定量限根据化合物不同,范围为3至25 ng/mL。在自动化SPE系统中未观察到交叉污染。提取的样本在自动进样器(4°C)中72小时内稳定。该方法应用于真实样本(来自法医和毒理学案例)以及含有可卡因、海洛因、丁丙诺啡和美沙酮的能力验证方案,提供了快速可靠的结果。自动化提高了精密度和准确性,且操作人员干预最少,从而实现了更安全的样本处理和耗时更少的程序。